Fouad Abuzeid, MD
Neurocritical Care · Port St Lucie, FLNPI 1255793642
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $268 of the $323 with a category attached, or 83.0%. 6 manufacturers reported payments, led by Viiv Healthcare Company at 36.1% of the total. Reporting peaked in 2019 at $131 and has fallen 88.4% since, to $15 in 2023.
Across 13 payments — averaging $24.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$117
- Sanofi$103
- Acorda Therapeutics, Inc$55
- Sanofi-aventis U.S. LLC$19
- MML US, Inc.$15
- Genentech USA, Inc.$13
What the payments were for
- Speaking & faculty fees$5517%
- Food & beverage$26883%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 1 | $117 |
| Sanofi | 5 | $103 |
| Acorda Therapeutics, Inc | 3 | $55 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| MML US, Inc. | 2 | $15 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CABENUVA$117
How this compares
$323 in reported general payments places this provider in the 55th percentile of 36 neurocritical care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurocritical care in Port St Lucie
- Marc-Alain BabiPort St Lucie$812
- Abhi PandhiMiami$16K
- Kristine O PhelanMiami$7K
- Michael CrimminsAventura$6K
- Fadar OtiteMiami$5K
- Mubashir PervezWeston$3K
- Katharina BuslGainesville$1K
- Ashley RogersJacksonville$1K
- Bassel RaadOrlando$609
- Micah SyJacksonville$605
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.